Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren P Mason

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Current Oncology (Toronto, Ont.)|September 27, 2023
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An UpdateRoa Alsajjan, Warren P Mason
Neuro-Oncology|April 3, 2018
mTOR inhibition in glioblastoma: requiem for a dream?Sam Babak, Warren P Mason
Hematology/Oncology Clinics of North America|November 23, 2006
The changing management of low-grade astrocytomas and oligodendrogliomasMark Agulnik, Warren P Mason
Neurology|July 30, 2008
Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomasWarren P Mason, J Gregory Cairncross
Handbook of Clinical Neurology|January 11, 2012
Anaplastic astrocytomasAyman I Omar, Warren P Mason
Expert Review of Anticancer Therapy|May 19, 2012
Antiangiogenic therapies in glioblastoma multiformeMairéad G McNamara, Warren P Mason
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trialWarren P Mason, J Gregory Cairncross
CNS Drugs|June 2, 2023
BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic TargetsThiago P Muniz, Warren P Mason
Core Evidence|August 10, 2010
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomasAyman I Omar, Warren P Mason
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Management of glioblastoma in the elderlySolmaz Sahebjam, Mairead McNamara, Warren P Mason
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|September 27, 2023
Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An UpdateRoa Alsajjan, Warren P Mason
Neuro-Oncology|April 3, 2018
mTOR inhibition in glioblastoma: requiem for a dream?Sam Babak, Warren P Mason
Hematology/Oncology Clinics of North America|November 23, 2006
The changing management of low-grade astrocytomas and oligodendrogliomasMark Agulnik, Warren P Mason
Neurology|July 30, 2008
Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomasWarren P Mason, J Gregory Cairncross
Handbook of Clinical Neurology|January 11, 2012
Anaplastic astrocytomasAyman I Omar, Warren P Mason
Expert Review of Anticancer Therapy|May 19, 2012
Antiangiogenic therapies in glioblastoma multiformeMairéad G McNamara, Warren P Mason
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trialWarren P Mason, J Gregory Cairncross
CNS Drugs|June 2, 2023
BRAF Mutations in CNS Tumors-Prognostic Markers and Therapeutic TargetsThiago P Muniz, Warren P Mason
Core Evidence|August 10, 2010
Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomasAyman I Omar, Warren P Mason
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
Management of glioblastoma in the elderlySolmaz Sahebjam, Mairead McNamara, Warren P Mason
Pageof 12